Genetic Agency Technology Conference (GATC) 2025

A one-day gathering for therapeutic developers, technologists, AI pioneers, and entrepreneurs, together with patients and their advocates, to co-create the future of genetic medicine

November 11, 2025
Boston Seaport (Westin)

About GATC

We are working to build a world with “genetic agency”: a person’s ability to make informed choices and take action at the DNA level to live a healthier life. It’s a term we’ve started using to highlight the importance of creating therapeutic options where none exist today, and to recognize the efforts of patients and their families who work to develop these medicines themselves rather than to give up hope. To help make this happen, Dyno is hosting a Genetic Agency Technology Conference (GATC) in Boston on November 11. 

The conference is inspired by a vision of the future with patient-empowering genetic technologies that are safe, effective and accessible to all — and the recognition that we will need to overcome major challenges, technological and otherwise, for all of these treatments to become a reality. This future can’t be realized by any one actor alone — it requires a community working together with pace to turn powerful emerging technologies into patient impact.

At GATC we’re bringing together leaders from various sectors: therapeutic developers, technologists, AI pioneers, and entrepreneurs along with patients and their advocates. Topics at this meeting will include state of the art gene delivery and AI for sequence design as enabling technologies, and other areas of interest to attendees such as preclinical development, manufacturing and regulatory pathways. 

The day will include highly participatory sessions emphasizing connection and conversation. Our assumption is that everyone who attends comes with expertise and a goal.

Why Attend

Empower

Elevate the voices of patients and their advocates as critical experts shaping the next generation of genetic technologies

Connect

Build lasting relationships across the gene therapy ecosystem that are rooted in a shared commitment to advancing genetic agency

Engage

Spark meaningful and candid conversations to challenge norms and bridge the gap between technology innovation and real patient impact

Activate

Gain actionable insights to translate learnings into better treatment options today and goals for future technology development that align with patient priorities

Featured Speakers

Our exciting lineup of speakers includes:

  • Head shot of George

    George Church, PhD

    Founding Core Faculty and Synthetic Biology Lead at the Wyss Institute

  • Headshot of Sonia

    Sonia Vallabh, PhD

    Director of Prion Therapeutic Science at the Broad Institute

  • Headshot of Federico

    Federico Mingozzi, PhD

    CEO of Nava Therapeutics and ASGCT Treasurer

  • Head shot of Terence

    Terence Flotte, MD

    Provost, Dean, Professor at UMass Chan Medical School and ASGCT President

  • Head shot of Victoria Gray

    Victoria Gray

    First patient treated with CRISPR gene editing therapy for Sickle Cell Disease

More speakers will be announced soon.

Schedule

November 11, 2025

  • 8:00 am - 5:00 pm

    Conference Programming

  • 5:00 pm - 7:00 pm

    Reception and Happy Hour Social

FAQ

Interested in taking part in GATC 2025?

GATC is an invitation-only event, though a limited number of spots are available for those who apply to attend. We welcome anyone interested to submit an application, no later than Oct 10.

Apply to attend